TWO YEAR RESULTS FROM THE COMPARE-ACUTE TRIAL

نویسندگان
چکیده

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Two-year results from a randomized clinical trial of revascularization in patients with intermittent claudication.

BACKGROUND Intermittent claudication is associated with significant impairment of health-related quality of life. The use of revascularization techniques to improve health-related quality of life remains controversial. METHODS Patients with intermittent claudication due to iliac or femoropopliteal peripheral artery disease were enrolled in the IRONIC trial. They were randomized to either best...

متن کامل

Short-Term Results of the DePuy Global Unite Platform Shoulder System: A Two-Year Outcome Study

Background: The Global Unite Shoulder System is the next generation of implant from the Depuy Global Shoulderline. The primary feature of the Global Unite is adaptability through the interchangeable modular bodies, modular suturecollars, and stems. Short-term functional and radiographic outcomes of the Global Unite Platform Shoulder Systemwere assessed as well as complication and revision rates...

متن کامل

Is it appropriate to compare the results from two clinical trials with one drug in common?

factor to be considered when determining patient suitability for transcatheter implantation. Variables such as calcium quantity and distribution, the width of the sinuses of Valsalva, outflow tract diameter or computed tomography-measured annulus diameter (maximum annulus diameter was 23.9 mm) must also be analyzed. Since percutaneous implantation techniques began to be used for aortic valves, ...

متن کامل

Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial.

CONTEXT At 30-day follow-up, patients with moderate- and high-risk acute coronary syndromes (ACS) undergoing early invasive treatment in the ACUITY trial with bivalirudin monotherapy vs heparin plus glycoprotein (GP) IIb/IIIa inhibitors had noninferior rates of adverse ischemic events with reduced rates of major bleeding. Deferred upstream use of GP IIb/IIIa inhibitors for selective administrat...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Journal of the American College of Cardiology

سال: 2018

ISSN: 0735-1097

DOI: 10.1016/s0735-1097(18)31699-1